Shares of medical imaging company Nano-X Imaging (NASDAQ: NNOX)-- commonly referred to as Nanox -- went up on Thursday after some pretty substantial news broke regarding regulatory clearance. At 10:50 ...

Before market open, Nanox unveiled its fourth-quarter results, which showed that the company booked $3 million in revenue, which was an improvement over the $2.4 million it collected in the same ...

Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and proprietary ...

Nano-X Imaging Ltd. (Nasdaq: NNOX) said it is collaborating with Monarch Medical Management to install Nanox’s imaging solutions at healthcare segments like workers’ compensation, nursing home ...

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in the U.S. New clinical data supporting use of Nanox.ARC ...

The FDA gave clearance for Nanox's flagship 3D X-ray imaging device -- a huge development. The company still has to execute on the rest of its plan, and management expects that it will need to raise ...

Shares of medical-imaging company Nano-X Imaging (NASDAQ: NNOX), commonly referred to as Nanox, plunged on Tuesday following the release of financial results for the second quarter of 2021. The ...

Nanox's net loss widened in the second quarter. The company is acquiring two companies but is funding these deals primarily with stock. It announced several changes to its executive leadership team.